InsidersTradesSigma
Follow the U.S. NeuroSurgical Holdings, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 26 September 2022 (Attribution). Among the most active insiders: Leimkuhler William F.. Every trade is accessible without an account.
Analysts rate U.S. NeuroSurgical Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
U.S. NeuroSurgical Holdings, Inc. is a company focused on neurosurgery. It specializes in the development and commercialization of innovative technologies and services for healthcare professionals.